AlternativeMed
Ancient Wisdom Natural Remedies Modern Wellness
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

🌿
Herb
6,826
→
⚗️
Ingredient
44,595
→
🧬
Gene Target
15,505
→
🏥
Disease
30,170
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
Subject Type: 🌿 Herbs ⚗️ Ingredients 📜 Formulas 🧬 Targets 🏥 Diseases
Quick picks: Abetalipoproteinemia Abortion, Habitual Agenesis Acanthamoeba Keratitis Acanthosis Nigricans Achondrogenesis Achondroplasia Acne Vulgaris Acne Keloid Apert Syndrome
🏥 Disease / Health Topic

Breast Carcinoma

Open on HERB 2.0 ↗
37
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT01975363
Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer
Completed
NCT04150042
SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells
Recruiting · Phase 1
NCT00770809
Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
Active_Not_Recruiting · Phase 3
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Breast Carcinoma
🏥 Names
Disease Name
Breast Carcinoma
Alias Names
Malignant Neoplasm of Breast; Breast Carcinoma; Mammary Carcinoma, Human; Breast Cancer; Breast Neoplasms; Mammary Neoplasms, Human
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
MeSH Class
Skin and Connective Tissue Diseases; Neoplasms
HPO Class
Neoplasm; Abnormality of the breast
DO Class
disease of anatomical entity; disease of cellular proliferation
🔗 External References
HERB DB
HBDIS010533 ↗
MeSH
D001943 ↗
HPO
HP:0003002 ↗
Disease Ontology
3459
DisGeNET
C0678222
🔍 Raw view — every non-empty column on this row (29 fields)
name
Breast Carcinoma
alias name
Malignant Neoplasm of Breast; Breast Carcinoma; Mammary Carcinoma, Human; Breast Cancer; Breast Neoplasms; Mammary Neoplasms, Human
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
mesh disease class
Skin and Connective Tissue Diseases; Neoplasms
hpo disease class
Neoplasm; Abnormality of the breast
do disease class
disease of anatomical entity; disease of cellular proliferation
umls disease type id
T191
mesh disease class id
C04; C17
hpo disease class id
HP:0000769; HP:0002664
do disease class id
DOID:14566; DOID:7
herb disease id
HBDIS010533
disgenet id
C0678222
mesh id
D001943
hpo id
HP:0003002
do id
3459

🌿 Related Herbs

1 · shared evidence
Glossy Ganoderma; Lucid Ganoderma

⚗️ Related Ingredients

4 · shared evidence
Curcumin
Femara
L-ascorbic acid
Taxol

📋 Clinical Trials

12 · subject of clinical study
NCT01975363 Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer
→ Atypical Ductal Breast Hyperplasia|BRCA1 Gene Muta
NCT04150042 SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Usi
→ Pancreatic Adenocarcinoma Metastatic|BRCA1 Mutatio
NCT00770809 Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With S
→ Male Breast Carcinoma|Stage IIA Breast Cancer AJCC
NCT00785291 Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treati
→ Estrogen Receptor Negative|Estrogen Receptor Posit
NCT00861705 Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubici
→ Male Breast Carcinoma|Stage IIA Breast Cancer AJCC
NCT01091428 Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal C
→ Ovarian Carcinoma|Fallopian Tube Cancer|Peritoneal
NCT01263145 MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic S
→ Adult Solid Neoplasm|Recurrent Breast Carcinoma|St
NCT01276496 Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced So
→ Adult Solid Neoplasm|Estrogen Receptor Negative|HE
NCT01281150 Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients Wi
→ Adult Solid Neoplasm|Estrogen Receptor Negative|Es
NCT01366144 Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors Th
→ Breast Carcinoma|Carcinoma of Unknown Primary|Endo
NCT01730833 Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulat
→ HER2-positive Breast Cancer|Recurrent Breast Cance
NCT01750073 Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Trea
→ Estrogen Receptor Negative|Estrogen Receptor Posit
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: empty — needs HERB_herb_ingredient import
  • Ingredient ↔ Target: empty — needs HERB_ingredient_target import
  • Target ↔ Disease: empty — needs HERB_target_disease import
  • Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables